(VIANEWS) – TIETOEVRY (TIETO.OL), AEGON (AGN.AS), INNATE PHARMA (IPH.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| TIETOEVRY (TIETO.OL) | 7.46% | 2024-04-04 08:44:02 |
| AEGON (AGN.AS) | 5.79% | 2024-04-04 08:00:11 |
| INNATE PHARMA (IPH.PA) | 4.64% | 2024-03-31 07:46:58 |
| TRIGANO (TRI.PA) | 2.4% | 2024-03-31 08:01:37 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. TIETOEVRY (TIETO.OL)
7.46% Foward Dividend Yield
TIETOEVRY’s last close was kr227.60, 34.86% below its 52-week high of kr349.40. Intraday change was -0.44%.
TietoEVRY Oyj operates as a software and services company. It operates through five segments: Tietoevry Create, Tietoevry Banking, Tietoevry Care, Tietoevry Industry, and Tietoevry Tech Services. The Tietoevry Create segment provides digital agenda to create competitive products, as well as uses design, data, and cloud technologies for data-driven businesses. This segment also offers software and data engineering services. The Tietoevry Banking segment provides Banking-as-a-Service platform and software products for digital transformation and financial institutions. The Tietoevry Care segment offers modular and interoperable software, reinventing Nordic health, and social care services. The Tietoevry Industry segment offers software and data solutions to various industries, such as public sector, pulp and paper, and utilities. The Tietoevry Tech Services provides enterprise-wide transformation to customers' business processes, applications and infrastructure; and deep customer knowledge, global cloud & data competencies, automated operations, and multi-cloud platform services. The company was formerly known as Tieto Oyj and changed its name to TietoEVRY Oyj in December 2019. TietoEVRY Oyj was incorporated in 1968 and is headquartered in Espoo, Finland.
Earnings Per Share
As for profitability, TIETOEVRY has a trailing twelve months EPS of kr16.84.
PE Ratio
TIETOEVRY has a trailing twelve months price to earnings ratio of 13.46. Meaning, the purchaser of the share is investing kr13.46 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.
Yearly Top and Bottom Value
TIETOEVRY’s stock is valued at kr226.60 at 12:50 EST, way under its 52-week high of kr349.40 and above its 52-week low of kr223.20.
Volatility
TIETOEVRY’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.36%, a negative 0.19%, and a positive 1.14%.
TIETOEVRY’s highest amplitude of average volatility was 0.98% (last week), 1.20% (last month), and 1.14% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TIETOEVRY’s stock is considered to be overbought (>=80).
Moving Average
TIETOEVRY’s worth is below its 50-day moving average of kr243.65 and under its 200-day moving average of kr250.11.
More news about TIETOEVRY.
2. AEGON (AGN.AS)
5.79% Foward Dividend Yield
AEGON’s last close was €5.77, 2.3% higher than its 52-week high of €5.64. Intraday change was 0.8%.
Aegon Ltd. provides insurance, pensions, retirement, and asset management services in the Americas, the Netherlands, the United Kingdom, and internationally. The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, and mutual funds; mortgage loans; and individual retirement accounts, as well as stable value, investment management, and digital banking solutions. It offers its products under the Aegon and Transamerica brands. The company was founded in 1844 and is headquartered in The Hague, the Netherlands.
Earnings Per Share
As for profitability, AEGON has a trailing twelve months EPS of €-0.7.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.52%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.1%, now sitting on -13.41B for the twelve trailing months.
Yearly Top and Bottom Value
AEGON’s stock is valued at €5.79 at 12:50 EST, above its 52-week high of €5.64.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2024, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 5.79%.
More news about AEGON.
3. INNATE PHARMA (IPH.PA)
4.64% Foward Dividend Yield
INNATE PHARMA’s last close was €2.27, 40.39% below its 52-week high of €3.80. Intraday change was -0.23%.
Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), an Anti-C5aR Antibody; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH4501, an antibody drug conjugates (ADC); and IPH65, a tetra-specific proprietary antibody. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France.
Earnings Per Share
As for profitability, INNATE PHARMA has a trailing twelve months EPS of €-0.79.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.91%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 4.64%.
More news about INNATE PHARMA.
4. TRIGANO (TRI.PA)
2.4% Foward Dividend Yield
TRIGANO’s last close was €157.80, 2.73% higher than its 52-week high of €153.60. Intraday change was 9.99%.
Trigano S.A., together with its subsidiaries, designs, manufactures, markets, and sells leisure vehicles for individuals and professionals in Europe. It offers camping cars, caravans, motorhomes, trailers, and outdoor habitats. The company also provides mobiles homes, spare parts, and accessories, as well as leisure financing services. It offers its products through dealer networks and distributors, as well as through its online sales site, Triganostore.com. Trigano S.A. was founded in 1935 and is based in Paris, France.
Earnings Per Share
As for profitability, TRIGANO has a trailing twelve months EPS of €15.95.
PE Ratio
TRIGANO has a trailing twelve months price to earnings ratio of 10.22. Meaning, the purchaser of the share is investing €10.22 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.93%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 17, 2024, the estimated forward annual dividend rate is 3.5 and the estimated forward annual dividend yield is 2.4%.
Volume
Today’s last reported volume for TRIGANO is 123943 which is 616.76% above its average volume of 17292.
Volatility
TRIGANO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.65%, a positive 0.34%, and a positive 1.09%.
TRIGANO’s highest amplitude of average volatility was 1.65% (last week), 1.47% (last month), and 1.09% (last quarter).
More news about TRIGANO.
